About: http://data.cimple.eu/news-article/7ee3dca49081cbc4f401963a66a6b967dccd8cb17ca2ff7b04b877ee

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/7ee3dca49081cbc4f401963a66a6b967dccd8cb17ca2ff7b04b877ee Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Moderna said Thursday it took in $1.1 billion in deposits in the third quarter for a coronavirus vaccine that it is "actively preparing" to launch. The biotech company, releasing quarterly results, completed its enrollment earlier this month for the phase-3 trial of "mRNA-1273," a vaccine candidate for Covid-19. "We are actively preparing for the launch of mRNA-1273 and we have signed a number of supply agreements with governments around the world," said Moderna chief executive Stephane Bancel. "I believe that if we launch our Covid-19 vaccine, 2021 could be the most important inflection year in Moderna's history. We will have the resources to scale Moderna to maximize the impact we can have on patients in the next 10 years through numerous new medicines." Moderna, among the furthest along in developing a vaccine for Covid-19, has signed supply contracts with the US, Canada, Switzerland, Japan, Israel and Qatar and is in talks with other parties, including the European Union. Moderna said there would be two interim analyses of the Covid-19 vaccine candidate and that the company is committed to "full transparency" in the development of the vaccine. The company, founded in 2010, reported a loss of $233.6 million in the third quarter on revenues of $157.9 million. The company had nearly $4.0 billion in cash at the end of the quarter, including more than $1 billion in deferred revenues connected to supply agreements with government agencies for future Covid-19 vaccine supply. jum-jmb/ft
schema:headline	Moderna already has $1.1 bn in deposits for Covid-19 vaccine
schema:mentions	Switzerland Qatar Japan Messenger RNA Israel Canada Vaccine United States Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Inflection
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-10-29 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	69 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software